Abstract
Serological markers for Chlamydia pneumoniae were investigated by using the microimmunofluorescence (MIF) test in various age and patient groups in a specific area in Turkey. IgG seropositivity to C. pneumoniae was 64.3% and 18.7% in healthy adults and children, respectively. The highest positivity rate (77%) was in the 15–19 age group. Among the groups investigated, serological findings revealed a possible etiological association between C. pneumoniae and the clinical condition in the groups with acute myocardial infarction, atypical pneumoniae and chronic obstructive pulmonary disease.
Similar content being viewed by others
References
Freidank HM, Brauer D. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students. J Infect 1993; 27: 89–93.
Karvonen M, Tuomiolehto J, Pitkaniemi J, et al. Chlamydia pneumoniae antibody prevalence in South-Western and Eastern Finland in 1983 and 1987. Int J Epidemiol 1994; 23: 176–184.
Kobayashi S, Morishita T, Miyake T, et al. Prevalence of Chlamydia pnenmoniae in Japan. J Infect Dis 1991; 163: 417–418.
Marton A, Karoly A, Szalka A. Prevalence of Chlamydia pneumoniae antibodies in Hungary. Eur J Clin Microbiol Infect Dis 1992; 11: 139–142.
Sundelöf B, Gnarpe J, Gnarpe H, et al. Chlamydia pneumoniae in Swedish patients. Scand J Infect Dis 1993; 25: 429–433.
Van den Abeele AM, Van Renterghem L, Willems K, et al. Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population. J Infect Dis 1992; Suppl 1: 87–90.
Wang SP, Grayston JT. Population prevalence of Chlamydia pneumoniae strain TWAR. In: Bowie WR, Caldwell HD, Jones RP, Mardh PA, Ridgway GL, Schachter J, Walter ES, Ward ME (eds), Chlamydial infections. Proceedings of the seventh international symposium on human chlamydial infections. Cambridge, UK: Cambridge University Press, 1990: 402–405.
Blasi F, Legnani D, Lombardo VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993; 6(1): 19–22.
Falck, G, Heyman L, Gnarpe J, et al. Chlamydia pneumoniae (TWAR): A common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 179–87.
Grayston JT., Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231–1235.
Hahn DL, Golubjatnikov R. Asthma and chlamydial infection: A case series. J Fam Pract 1994; 38(6): 589–595.
Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273–278.
Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988 (ii): 983–986.
Saikku P, Wang SP, Kleemola M, et al. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985; 151: 832–839.
Wang JH, Liu YC, Cheng DL, et al. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993; 25: 565–568.
Einarsson S, Sigurdsson HK, Magnusdottir SD, et al. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 1994; 26: 393–397.
Kleemola M, Saikku P, Visakorpi R, et al. Epidemics of Chlamydia pneumoniae caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 1988; 157: 230–236.
Saikku P. The epidemiology and significance of Chlamydia pneumoniae J Infect 1992; 25: 27–34.
Grayston JT. Chlamydia pneumoniae strain TWAR. Chest 1989; 95: 664–669.
Linnanmäki E, Leinonen M, Mattila K, et al. Chlamydia pneumoniae-specific circulating immune complex in patient with chronic coronary hearth disease. Circulation 1993; 4: 1130–1134.
Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993; 14(Suppl K): 62–65.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gencay, M., Dereli, D., Ertem, E. et al. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey. Eur J Epidemiol 14, 505–509 (1998). https://doi.org/10.1023/A:1007404315879
Issue Date:
DOI: https://doi.org/10.1023/A:1007404315879